266 related articles for article (PubMed ID: 36920859)
1. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia.
Tran DQ; Benson CC; Boice JA; Chitlur M; Dunn AL; Escobar MA; Gupta K; Johnsen JM; Jorgenson J; Martin SD; Martin S; Meeks SL; Narvaez AA; Quon DV; Reding MT; Reiss UM; Savage B; Schafer K; Steiner B; Thornburg C; Volland LM; von Drygalski A
Expert Rev Hematol; 2023 Mar; 16(sup1):19-37. PubMed ID: 36920859
[TBL] [Abstract][Full Text] [Related]
2. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities in health services; diversity, equity, and inclusion; and implementation science.
Byams VR; Baker JR; Bailey C; Connell NT; Creary MS; Curtis RG; Dinno A; Guelcher CJ; Kim M; Kulkarni R; Lattimore S; Norris KL; Ramirez L; Skinner MW; Symington S; Tobase P; Vázquez E; Warren BB; Wheat E; Buckner TW
Expert Rev Hematol; 2023 Mar; 16(sup1):87-106. PubMed ID: 36920863
[TBL] [Abstract][Full Text] [Related]
3. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research to advance the health of people with inherited bleeding disorders with the potential to menstruate.
Baldwin MK; Ahmadzia HK; Bartlett DL; Bensen-Kennedy D; Desai V; Haley KM; Herman-Hilker SL; Kilgore AM; Kulkarni R; Lavin M; Luckey S; Matteson KA; Paulyson-Nuñez K; Philipp CS; Ragosta S; Rosen K; Rotellini D; Weyand AC
Expert Rev Hematol; 2023 Mar; 16(sup1):71-86. PubMed ID: 36920864
[TBL] [Abstract][Full Text] [Related]
4. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders.
Nugent D; Acharya SS; Baumann KJ; Bedrosian C; Bialas R; Brown K; Corzo D; Haidar A; Hayward CPM; Marks P; Menegatti M; Miller ME; Nammacher K; Palla R; Peltier S; Pruthi RK; Recht M; Sørensen B; Tarantino M; Wolberg AS; Shapiro AD
Expert Rev Hematol; 2023 Mar; 16(sup1):55-70. PubMed ID: 36920862
[TBL] [Abstract][Full Text] [Related]
5. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders.
Sidonio RF; Bryant PC; Di Paola J; Hale S; Heiman M; Horowitz GS; Humphrey C; Jaffray J; Joyner LC; Kasthuri R; Konkle BA; Kouides PA; Montgomery R; Neeves K; Randi AM; Scappe N; Tarango C; Tickle K; Trapane P; Wang M; Waters B; Flood VH
Expert Rev Hematol; 2023 Mar; 16(sup1):39-54. PubMed ID: 36920856
[TBL] [Abstract][Full Text] [Related]
6. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding.
Ragni MV; Young G; Batsuli G; Bisson E; Carpenter SL; Croteau SE; Cuker A; Curtis RG; Denne M; Ewenstein B; Federizo A; Frick N; Funkhouser K; George LA; Hoots WK; Jobe SM; Krava E; Langmead CJ; Lewis RJ; López J; Malec L; Mann Z; Miles ME; Neely E; Neufeld EJ; Pierce GF; Pipe SW; Pitler LR; Raffini L; Schnur KM; Shavit JA
Expert Rev Hematol; 2023 Mar; 16(sup1):107-127. PubMed ID: 36920855
[TBL] [Abstract][Full Text] [Related]
7. Building the blueprint: Formulating a community-generated national plan for future research in inherited bleeding disorders.
Valentino LA; Witkop ML; Santaella ME; DiMichele D; Recht M
Haemophilia; 2022 Sep; 28(5):760-768. PubMed ID: 35700441
[TBL] [Abstract][Full Text] [Related]
8. The National Hemophilia Foundation State of the Science Research Summit initiative: executive summary.
Valentino LA; Witkop ML; Santaella ME; DiMichele D; Recht M
Expert Rev Hematol; 2023 Mar; 16(sup1):129-134. PubMed ID: 36920857
[TBL] [Abstract][Full Text] [Related]
9. The National Hemophilia Foundation's State of the Science Research Summit: the foundation of a national research blueprint for inherited bleeding disorders.
Valentino LA; Witkop ML; Santaella ME; DiMichele D; Recht M
Expert Rev Hematol; 2023 Mar; 16(sup1):1-5. PubMed ID: 36920858
[No Abstract] [Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Big picture initiatives in bleeding disorders.
Rauch A; Valentino LA; Mills K; Witkop ML; Santaella ME; DiMichele D; Recht M; Susen S
Haemophilia; 2022 May; 28 Suppl 4():53-60. PubMed ID: 35521733
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of CDC's Hemophilia Surveillance Program - Universal Data Collection (1998-2011) and Community Counts (2011-2019), United States.
Schieve LA; Byams VR; Dupervil B; Oakley MA; Miller CH; Soucie JM; Abe K; Bean CJ; Hooper WC
MMWR Surveill Summ; 2020 Sep; 69(5):1-18. PubMed ID: 32881847
[TBL] [Abstract][Full Text] [Related]
13. Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community.
Robinson F; Wilkes S; Schaefer N; Goldstein M; Rice M; Gray J; Meyers S; Valentino LA
Ther Adv Drug Saf; 2023; 14():20420986221146418. PubMed ID: 36861041
[TBL] [Abstract][Full Text] [Related]
14. The Minderoo-Monaco Commission on Plastics and Human Health.
Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
[TBL] [Abstract][Full Text] [Related]
15. Hemophilia Management via Data Collection and Reporting: Initial Findings from the Comprehensive Care Sustainability Collaborative.
Tarantino MD; Pindolia VK
J Manag Care Spec Pharm; 2017 Jan; 23(1):51-56. PubMed ID: 28025929
[TBL] [Abstract][Full Text] [Related]
16. Overcoming the challenges of treating hemophilia in resource-limited nations: a focus on medication access and adherence.
Ghosh K; Ghosh K
Expert Rev Hematol; 2021 Aug; 14(8):721-730. PubMed ID: 34278926
[TBL] [Abstract][Full Text] [Related]
17. Common themes and challenges in hemophilia care: a multinational perspective.
Stoffman J; Andersson NG; Branchford B; Batt K; D'Oiron R; Escuriola Ettingshausen C; Hart DP; Jiménez Yuste V; Kavakli K; Mancuso ME; Nogami K; Ramírez C; Wu R
Hematology; 2019 Dec; 24(1):39-48. PubMed ID: 30073913
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive care for hemophilia and other inherited bleeding disorders.
Page D
Transfus Apher Sci; 2019 Oct; 58(5):565-568. PubMed ID: 31427262
[TBL] [Abstract][Full Text] [Related]
19. Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH.
Konkle B; Pierce G; Coffin D; Naccache M; Clark RC; George L; Iorio A; O'Mahony B; Pipe S; Skinner M; Watson C; Peyvandi F; Mahlangu J;
J Thromb Haemost; 2020 Nov; 18(11):3074-3077. PubMed ID: 33463024
[TBL] [Abstract][Full Text] [Related]
20. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
